Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition
Randomized Phase I study examining the effects of gabapentinoids gabapentin, pregabalin and gastroretentive gabapentin on simulated driving performance, sedation and cognitive function in healthy volunteers (n = 32). Driving attentiveness, sleepiness and cognition were evaluated prior to subjects re...
Saved in:
Published in | Pain management Vol. 8; no. 4; pp. 297 - 306 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Randomized Phase I study examining the effects of gabapentinoids gabapentin, pregabalin and gastroretentive gabapentin on simulated driving performance, sedation and cognitive function in healthy volunteers (n = 32).
Driving attentiveness, sleepiness and cognition were evaluated prior to subjects receiving study doses. Blood samples were collected during each treatment.
Subjects receiving gastroretentive gabapentin showed less change in variation in lateral lane position (p = 0.0275), less tremor (p = 0.0304) and fewer vision disturbances compared with gabapentin (p = 0.0177). Statistically significant decrease in One Card Learning Test performance was observed after treatment with gastroretentive gabapentin.
Gastroretentive gabapentin demonstrated reduced driving impairment and lower scores on key neurotoxicity measures. Further studies in patients with postherpetic neuralgia are needed.
Clinical trial number: NCT03179345 |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ISSN: | 1758-1869 1758-1877 |
DOI: | 10.2217/pmt-2018-0005 |